Correlation Between Gap, and Dogwood Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Gap, and Dogwood Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gap, and Dogwood Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between The Gap, and Dogwood Therapeutics,, you can compare the effects of market volatilities on Gap, and Dogwood Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gap, with a short position of Dogwood Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gap, and Dogwood Therapeutics,.
Diversification Opportunities for Gap, and Dogwood Therapeutics,
-0.71 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Gap, and Dogwood is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding The Gap, and Dogwood Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dogwood Therapeutics, and Gap, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on The Gap, are associated (or correlated) with Dogwood Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dogwood Therapeutics, has no effect on the direction of Gap, i.e., Gap, and Dogwood Therapeutics, go up and down completely randomly.
Pair Corralation between Gap, and Dogwood Therapeutics,
Considering the 90-day investment horizon The Gap, is expected to generate 0.71 times more return on investment than Dogwood Therapeutics,. However, The Gap, is 1.41 times less risky than Dogwood Therapeutics,. It trades about 0.13 of its potential returns per unit of risk. Dogwood Therapeutics, is currently generating about -0.11 per unit of risk. If you would invest 2,204 in The Gap, on September 22, 2024 and sell it today you would earn a total of 207.00 from holding The Gap, or generate 9.39% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
The Gap, vs. Dogwood Therapeutics,
Performance |
Timeline |
Gap, |
Dogwood Therapeutics, |
Gap, and Dogwood Therapeutics, Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Gap, and Dogwood Therapeutics,
The main advantage of trading using opposite Gap, and Dogwood Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gap, position performs unexpectedly, Dogwood Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dogwood Therapeutics, will offset losses from the drop in Dogwood Therapeutics,'s long position.The idea behind The Gap, and Dogwood Therapeutics, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Dogwood Therapeutics, vs. The Gap, | Dogwood Therapeutics, vs. Sea | Dogwood Therapeutics, vs. Grocery Outlet Holding | Dogwood Therapeutics, vs. Asbury Automotive Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
CEOs Directory Screen CEOs from public companies around the world | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Share Portfolio Track or share privately all of your investments from the convenience of any device |